Piper Sandler reiterates Overweight rating on Globe Life stock

Published 21/11/2025, 15:16
Piper Sandler reiterates Overweight rating on Globe Life stock

Investing.com - Piper Sandler has reiterated its Overweight rating on Globe Life (NYSE:GL) with a price target of $167.00, identifying the insurance company as a "4Q25 favorite idea." This target represents nearly 28% upside from the current price of $130.37, aligning with the broader analyst consensus that shows an average upside potential of 28% according to InvestingPro data.

The firm highlighted Globe Life’s consistent pattern of setting conservative annual guidance, typically being the first in the life insurance sector to do so. Piper Sandler’s analysis of the past decade suggests potential for the initial 2026 EPS guidance range of $14.60-$15.30 to reach a mid-point of $15.50-$16.40 after final revisions. The company reported diluted EPS of $13.77 over the last twelve months, with analysts forecasting $15.11 for fiscal year 2025.

The research firm pointed to Globe Life’s captive distribution as an exemplary "niches are for riches" business model, giving the company a competitive advantage in the market.

Piper Sandler also noted that competitor CNO’s recent expansion in Bermuda suggests potential for Globe Life’s own Bermuda operations to grow over time, creating additional value opportunities.

The firm believes the removal of investigation headwinds could help Globe Life shares approach the company’s 10-year historic valuation multiple of 11.7x, compared to current multiples of 8.5x for 2026 estimates and 7.9x for 2027 estimates.

In other recent news, Globe Life Inc. reported its third-quarter earnings for 2025, showing a robust performance in earnings per share (EPS), which exceeded expectations. The company posted an EPS of $4.73, surpassing the forecast of $4.60. However, the revenue came in slightly below expectations at $1.51 billion, compared to the anticipated $1.52 billion. Keefe, Bruyette & Woods responded by raising its price target for Globe Life from $160 to $162, maintaining an Outperform rating. The firm cited higher life margins and share buybacks as key factors for the upward revision, despite lower excess net investment income. Additionally, Globe Life’s Board of Directors declared a quarterly dividend of $0.27 per share, payable on January 30, 2026, to shareholders of record as of January 5, 2026. These developments reflect the company’s ongoing financial strategies and market positioning.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.